Loss of expression of TGF-β1, TβRI, and TβRII correlates with differentiation in human oral squamous cell carcinomas

International Journal of Oncology

Volumn 32, Issue 2, 2008, Pages 323-331

  Mincione, Gabriella ^a   Di Marcantonio, Maria Carmela ^a   Artese, Luciano ^a   Vianale, Giovina ^a   Piccirelli, Alessandro ^a   Piccirilli, Marcello ^a   Perrotti, Vittoria ^a   Rubini, Corrado ^b   Piattelli, Adriano ^a   Muraro, Raffaella ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

ALK 5; Involucrin; Oral squamous cell carcinoma; Squamous carcinoma cell lines; TGF receptors; Transforming growth factor 1; Tumor differentiation; T RI; T RII

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

EID: 38849184087     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.32.2.323     Document Type: Article

References (36)

1. Nair S and Pillai MR: Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers. Oral Dis 11: 350-359, 2005.
2. Schliephake H: Prognostic relevance of molecular markers of oral cancer - a review. Int J Oral Maxillofac Surg 32: 233-245, 2003.
3. Bei R, Budillon A, Masuelli L, Cereda V, Vitolo D, Di Gennaro E, Ripavecchia V, Palumbo C, Ionna F, Losito S, Modesti A, Kraus MH and Muraro R: Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients. J Pathol 204: 317-325, 2004.
4. Piek E, Heldin CH and Ten Dijke P: Specificity, diversity, and regulation in TGF-β superfamily signalling. FASEB J 13: 2105-2124, 1999.
5. Lopez-Casillas F, Wrana JL and Massagué J: Betaglycan presents ligand to the TGF-β signalling receptor. Cell 73: 1435-1444, 1993.
6. Coffey RJ, Bascom CC, Sipes NJ, Graves-Deal R, Weissman BE and Moses HL: Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β. Mol Cell Biol 8: 3088-3093, 1988.
7. Hung LM, Tsai CH and Chen JK: TGF-β1 selectively suppresses PDGF receptor signalling pathways in MG-63 human osteosarcoma cell. Life Sci 61: 685-693, 1997.
8. Chambard JC and Pouyssegur J: TGF-β inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events. J Cell Physiol 135: 101-107, 1988.
9. Ulloa L, Doody J and Massagué J: Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature 397: 710-713, 1999.
10. Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M and Bottinger EP: A mechanism of suppression of TGF-β/SMAD signalling by NF-kappa B/RelA. Gene Dev 14: 187-197, 2000.
11. Pierce DF Jr, Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ Jr and Moses HL: Mammary tumor suppression by transforming growth factor-β1 transgene expression. Proc Natl Acad Sci USA 92: 4254-4258, 1995.
12. Akhurst RJ and Derynck R: TGF-β signalling in cancer - a double-edged sword. Trends Cell Biol 11: S44-S51, 2001.
13. Muro-Cacho CA, Anderson M, Cordero J and Muñoz-Antonia T: Expression of Transforming Growth Factor β type II receptors in Head and Neck squamous cell carcinoma. Clin Cancer Res 5: 1243-1248, 1999.
14. Muro-Cacho CA, Rosario-Ortiz K, Livingston S and Muñoz-Antonia T: Defective Transforming Growth Factor β signalling pathway in Head and Neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2. Clin Cancer Res 7: 1618-1626, 2001.
15. Piazza GA, Ritter JL and Baracka CA: Lysophosphatidic acid induction of Transforming Growth Factors α and β: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp Cell Res 216: 51-64, 1995.
16. Ghahary A, Marcoux Y, Karimi-Busheri F and Tredged EE: Keratinocyte differentiation inversely regulates the expression of involucrin and Transforming Growth Factor β1. J Cell Biochem 83: 239-248, 2001.
17. Mincione G, Esposito DL, Di Marcantonio MC, Piccirelli A, Cama A and Colletta G: TGF-β1 modulation of IGF-I signaling pathway in rat thyroid epithelial cells. Exp Cell Res 287: 411-423, 2003.
18. Miyazono K, Olofsson A, Colosetti P and Heldin CH: A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1. EMBO J 10: 1091-1101, 1991.
19. Kretzschmar M, Doody J, Timokhina I and Massagué J: A mechanism of repression of TGFβ/Smad signalling by oncogenic Ras. Genes Dev 13: 804-816, 1999.
20. Cirafici AM, Pepe S, Mincione G, Esposito D and Colletta G: TGF-β inhibits rat thyroid cell proliferation without alterations in the expression of TSH-induced cell cycle-related genes. Biochem Biophys Res Commun 187: 225-233, 1992.
21. Coppa A, Mincione G, Mammarella S, Ranieri A and Colletta G: Epithelial rat thyroid cell clones, escaping from TGF β negative growth control, are still inhibited by this factor in the ability to trap iodide. Cell Growth Diff 6: 281-290, 1995.
22. Min BM, Woo KM, Lee G and Park NH: Terminal differentiation of normal human oral keratinocytes is associated with enhanced cellular TGF-β and phospholipase C-γ1 levels and apoptotic cell death. Exp Cell Res 49: 377-385, 1999.
23. Oh JE, Kook JK and Min BM: βig-h3 induces keratinocyte differentiation via modulation of involucrin and transglutaminase expression through the integrin α3β1 and the phosphatidyl-inositol 3-kinase/Akt signalling pathway. J Cell Biochem 280: 21629-21637, 2005.
24. Markowitz S, Wang J, Myeroff L, et al: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
25. Bottinger EP, Jakubczak JL, Haines DC, Bagnall K and Wakefield LM: Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor β receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene. Cancer Res 57: 5564-5570, 1997.
26. Chen T, Yan W, Wells RG, Rimm DL, McNiff J, Leffell D and Reiss M: Novel inactivating mutations of transforming growth factor-β type I receptor gene in head-and-neck cancer metastases. Int J Cancer 93: 653-661,2001.
27. Wang D, Song H, Evans JA, Lang JC, Schuller DE and Weghorst CM: Mutation and downregulation of the transforming growth factor β type II receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis 18: 2285-2290, 1997.
28. Paterson IC, Matthews JB, Huntley S, Robinson CM, Fahey M, Parkinson EK and Prime SS: Decreased expression of TGF-β cell surface receptors during progression of human oral squamous cell carcinoma. J Pathol 193: 458-467, 2001.
29. Gentry LE and Nash BW: The pro domain of pre-pro-transforming growth factor-β1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry 29: 6851-6857, 1990.
30. Theodorescu D, Bergsma D, Man MS, Elshourbagy N, Sheehan C, Rieman D and Kerbel RS: Cloning and overexpression of TGFβ1 cDNA in a mammary adenocarcinoma: in vitro and in vivo effects. Growth Factors 5: 305-316, 1991.
31. Dimberg J, Hugander A and Sirsjö A: Decreased levels of precursor transforming growth factor β1 in human colorectal cancer. Int J Mol Med 7: 597-601, 2001.
32. Reiss M and Stash EB: High frequency of resistance of human squamous carcinoma cells to the anti-proliferative action of transforming growth factor β. Cancer Commun 2: 363-369, 1990.
33. McAnulty RJ, Hernandez-Rodriguez NA, Mutsaers SE, Coker RK and Laurent GJ: Indomethacin suppresses the anti-proliferative effects of transforming growth factor-β isoforms on fibroblast cell cultures. Biochem J 321: 639-643, 1997.
34. Purps O, Lahme B, Gressner AM, Meindl-Beinker NM and Dooley S: Loss of TGF-β dependent growth control during HSC transdifferentiation. Biochem Biophys Res Commun 353: 841-847, 2007.
35. Qiu W, Schönleben F, Li X and Su GH: Disruption of transforming growth factor β-Smad signaling pathway in head and neak squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4. Cancer Lett 245: 163-170, 2007.
36. Reiss M, Santoro V, de Jonge RR and Vellucci VF: Transfer of chromosome 18 into human head and neck squamous carcinoma cells: evidence for tumor suppression by Smad4/DPC4. Cell Growth Differ 8: 407-415, 1997.